TRILLIUM THERAPEUTICS INC. Basic And Diluted Earnings Loss Per Share
TRILLIUM THERAPEUTICS INC. reported Basic And Diluted Earnings Loss Per Share of $1.65 per share for the 12-month period ending 2019-12-31, per its 40-F filed 2020-03-10.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicAndDilutedEarningsLossPerShare · last filed 2020-03-10
CAD/shares
| Period end | Basic And Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2018-12-31 | 3.06 CAD/shares 20-F · filed 2019-03-11 |
| 2017-12-31 | 4.61 CAD/shares 20-F · filed 2019-03-11 |
| 2016-12-31 | 4.06 CAD/shares 40-F · filed 2018-04-04 |
USD/shares
| Period end | Basic And Diluted Earnings Loss Per Share 12 month |
|---|---|
| 2019-12-31 | $1.65 40-F · filed 2020-03-10 |
| 2018-12-31 | $2.35 40-F · filed 2020-03-10 |